Regeneron & Sanofi Genzyme Join IPPF Corporate Council

Join us in welcoming our newest members of the IPPF Corporate Council, Regeneron & Sanofi Genzyme. At the beginning of 2020, the IPPF launched the Corporate Council as a collection of top stakeholders that are committed to facilitating collaboration and information exchange among patients, the IPPF, key opinion leaders, health-related organizations, and industry. We believe that only through an open and cooperative collaboration among all stakeholders will we effectively be able to address issues facing the pemphigus and pemphigoid (P/P) community.

The IPPF Corporate Council focuses on three areas of emphasis: access, advocacy, and awareness. Within these focus areas, the IPPF Corporate Council develops and supports activities and programs that ensure the IPPF fulfills its mission of improving the quality of life for all people affected by P/P through early diagnosis and support. Membership in the IPPF Corporate Council demonstrates an organization's leadership and commitment to addressing the challenges facing our patients. Involvement in the Council also provides the IPPF with an extended network of expertise and insight to ensure that we continue to address the unmet needs of all patients.

Please join us in welcoming our newest members to the 2020 IPPF Corporate Council